Influences of norepinephrine transporter function on the distribution of sympathetic activity in humans

Hypertension

Volumn 48, Issue 1, 2006, Pages 120-126

  Mayer, Antje F ^a   Schroeder, Christoph ^a   Heusser, Karsten ^a   Tank, Jens ^a   Diedrich, André ^b   Schmieder, Roland E ^c   Luft, Friedrich C ^a   Jordan, Jens ^a,d  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b VANDERBILT UNIVERSITY   (United States)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d FRANZ VOLHARD CLINIC   (Germany)

Author keywords

Norepinephrine; Renal circulation; Renin angiotensin system; Sympathetic nervous system

Indexed keywords

ANGIOTENSIN; NORADRENALIN TRANSPORTER; NORADRENALIN UPTAKE INHIBITOR; PLACEBO; REBOXETINE; ADRENERGIC RECEPTOR AFFECTING AGENT; ANGIOTENSIN II; MORPHOLINE DERIVATIVE; NORADRENALIN; RENIN;

ADRENERGIC SYSTEM; ADULT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; GLOMERULUS FILTRATION RATE; HEAD TILTING; HEART FUNCTION; HEART OUTPUT; HEART RATE; HUMAN; IMPEDANCE; KIDNEY BLOOD FLOW; KIDNEY CIRCULATION; KIDNEY FUNCTION; KIDNEY VASCULAR RESISTANCE; MALE; NORMAL HUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SUPINE POSITION; SYMPATHETIC TONE; SYSTOLIC BLOOD PRESSURE; VASCULAR RESISTANCE; BLOOD; BODY POSTURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG ANTAGONISM; DRUG EFFECT; HEMODYNAMICS; METABOLISM; RANDOMIZED CONTROLLED TRIAL;

ADRENERGIC UPTAKE INHIBITORS; ADULT; ANGIOTENSIN II; BLOOD PRESSURE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; GLOMERULAR FILTRATION RATE; HEART RATE; HEMODYNAMIC PROCESSES; HUMANS; MALE; MORPHOLINES; NOREPINEPHRINE; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; POSTURE; RENAL CIRCULATION; RENIN; SYMPATHETIC NERVOUS SYSTEM;

EID: 33746002931     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000225424.13138.5d     Document Type: Article

References (31)

1. Goldstein DS, Robertson D, Esler M, Straus SE, Eisenhofer G. Dysautonomias: clinical disorders of the autonomic nervous system. Ann Intern Med. 2002;137:753-763.
2. Jacob G, Biaggioni I. Idiopathic orthostatic intolerance and postural tachycardia syndromes. Am J Med Sci. 1999;317:88-101.
3. Esler M, Rumantir M, Kaye D, Lambert G. The sympathetic neurobiology of essential hypertension: disparate influences of obesity, stress, and noradrenaline transporter dysfunction? Am J Hypertens. 2001;14:139S-146S.
4. Grassi G, Facchini A, Trevano FQ, Dell'Oro R, Arenare F, Tana F, Bolla G, Monzani A, Robuschi M, Mancia G. Obstructive sleep apnea-dependent and -independent adrenergic activation in obesity. Hypertension. 2005;46:321-325.
5. Narkiewicz K, van de Borne PJ, Cooley RL, Dyken ME, Somers VK. Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation. 1998;98:772-776.
6. Rumantir MS, Kaye DM, Jennings GL, Vaz M, Hastings JA, Esler MD. Phenotypic evidence of faulty neuronal norepinephrine reuptake in essential hypertension. Hypertension. 2000;36:824-829.
7. Tank J, Schroeder C, Diedrich A, Szczech E, Haertter S, Sharma AM. Luft FC, Jordan J. Selective impairment in sympathetic vasomotor control with norepinephrine transporter inhibition. Circulation. 2003;107:2949-2954.
8. Esler MD, Wallin G, Dorward PK, Eisenhofer G, Westerman R, Meredith I, Lambert G, Cox HS, Jennings G. Effects of desipramine on sympathetic nerve firing and norepinephrine spillover to plasma in humans. Am J Physiol. 1991;260:R817-R823.
9. Schroeder C, Tank J, Boschmann M, Diedrich A, Sharma AM, Biaggioni I, Luft FC, Jordan J. Selective norepinephrine reuptake inhibition as a human model of orthostatic intolerance. Circulation. 2002;105:347-853.
10. Robertson D, Flattem N, Tellioglu T, Carson R, Garland E, Shannon JR, Jordan J, Jacob G, Blakely RD, Biaggioni I. Familial orthostatic tachycardia due to norepinephrine transporter deficiency. Ann NY Acad Sci. 2001;940:527-543.
11. Sherwood A, Allen MT, Fahrenberg J, Kelsey RM, Lovallo WR, van Doornen LJ. Methodological guidelines for impedance cardiography. Psychophysiology. 2002;27:1-23.
12. Hartter S, Weigmann H, Hiemke C. Automated determination of reboxetine by high-performance liquid chromatography with column-switching and ultraviolet detection. J Chromatogr B Biomed Sci Appl. 2000;740:135-140.
13. Schmieder RE, Schobel HP, Gatzka CE, Hauser W, Dominiak P, Mann JF, Luft FC. Effects of angiotensin converting enzyme inhibitor on renal haemodynamics during mental stress. J Hypertens. 1996;14:1201-1207.
14. Eisenhofer G, Goldstein DS, Stull R, Keiser HR, Sunderland T, Murphy DL, Kopin IJ. Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Clin Chem. 1986;32:2030-2033.
15. Montgomery SA. Predicting response: noradrenaline reuptake inhibition. Int Clin Psycho Pharmacol. 1999;14:S21-S26.
16. Eisenhofer G, Saigusa T, Esler MD, Cox HS, Angus JA, Dorward PK. Central sympathoinhibition and peripheral neuronal uptake blockade after desipramine in rabbits. Am J Physiol. 1991;260:R824-R832.
17. Cohen MD, Finberg J, Dibner-Dunlap M, Yuih SN, Thames MD. Effects of desipramine hydrochloride on peripheral sympathetic nerve activity. Am J Physiol. 1990;258:R876-R882.
18. Esler M, Jennings G, Lambert G, Meredith I, Horne M, Eisenhofer G. Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. Physiol Rev. 1990;70:963-985.
19. Goldstein DS, Brush JE, Eisenhofer G, Stull R, Esler M. In vivo measurement of neuronal uptake of norepinephrine in the human heart. Circulation. 1988;78:41-48.
20. Furlan R, Jacob G, Snell M, Robertson D, Porta A, Harris P, Mosqueda-Garcia R. Chronic orthostatic intolerance: a disorder with discordant cardiac and vascular sympathetic control. Circulation. 1998;98:2154-2159.
21. Birkenfeld AL, Schroeder C, Boschmann M, Tank J, Franke G, Luft FC, Biaggioni I, Sharma AM, Jordan J. Paradoxical effect of sibutramine on autonomic cardiovascular regulation. Circulation. 2002;106:2459-2465.
22. Shannon JR, Flattem NL, Jordan J, Jacob G, Black BK, Biaggioni I, Blakely RD, Robertson D. Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N Engl J Med. 2000;342:541-549.
23. DiBona GF. Neural control of renal function in health and disease. Clin Auton Res. 1994;4:69-74.
24. Kirchheim H, Ehmke H, Persson P. Sympathetic modulation of renal hemodynamics, renin release and sodium excretion. Klin Wochenschr. 1989;67:858-864.
25. Miki K, Hayashida Y, Tajima F, Iwamoto J, Shiraki K. Renal sympathetic nerve activity and renal responses during head-up tilt in conscious dogs. Am J Physiol. 1989;257:R337-R343.
26. Gullner HG. Regulation of sodium and water excretion by catecholamines. Life Sci. 1983;32:921-925.
27. Schroeder C, Adams F, Boschmann M, Tank J, Haertter S, Diedrich A, Biaggioni I, Luft FC, Jordan J. Phenotypical evidence for a gender difference in cardiac norepinephrine transporter function. Am J Physiol Regul Integr Comp Physiol. 2004;286:R851-R856.
28. Hahn MK, Mazei-Robison MS, Blakely RD. Single nucleotide polymorphisms in the human norepinephrine transporter gene impact expression, trafficking, antidepressant interaction and protein kinase C regulation. Mol. Pharmacol. 2005;68:457-466.
29. Esler M, Hastings J, Lambert G, Kaye D, Jennings G, Seals DR. The influence of aging on the human sympathetic nervous system and brain norepinephrine turnover. Am J Physiol Regul Integr Comp Physiol. 2002;282:R909-R916.
30. Meredith IT, Eisenhofer G, Lambert GW, Dewar EM, Jennings GL, Esler MD. Cardiac sympathetic nervous activity in congestive heart failure. Evidence for increased neuronal norepinephrine release and preserved neuronal uptake. Circulation. 1993;88:136-145.
31. Esler M, Kaye D. Sympathetic nervous system activation in essential hypertension, cardiac failure and psychosomatic heart disease. J Cardiovasc Pharmacol. 2000;35:S1-S7.